Pauline C. Ng, Sarah S. Murray, Samuel Levy and J. Craig Venter find differences in results from two direct-toconsumer genetics-testing companies. They therefore give nine recommendations to improve predictions.
This is a preview of subscription content, log in via an institution to check access.
References
Frazer, K. A., Murray, S. S., Schork, N. J. & Topol, E. J. Nature Rev. Genet. 10, 241–251 (2009).
Mailman, M. D. et al. Nature Genet. 39, 1181–1186 (2007).
Heshka, J. T., Palleschi, C., Howley, H., Wilson, B. & Wells, P. S. Genet. Med. 10, 19–32 (2008).
Hogarth, S., Javitt, G. & Melzer, D. Annu. Rev. Genomics Hum. Genet. 9, 161–182 (2008).
Duncan, D. E. Experimental Man: What One Man's Body Reveals About His Future, Your Health, and Our Toxic World (John Wiley & Sons, 2009).
Singer, E. Technology Review (MIT, 15 June, 2009); available at http://www.technologyreview.com/blog/editors/23680
Topol, E. J., Murray, S. S. & Frazer, K. A. J. Am. Med. Assoc. 298, 218–221 (2007).
Bertram, L., McQueen, M. B., Mullin, K., Blacker, D. & Tanzi, R.E. Nature Genet. 39, 17–23 (2007).
Hsu, A. & Naughton, B. (eds) Guidelines on Vetting Genetic Associations (23andMe; 2008); available at https://23andme.https.internapcdn.net/res/4400/pdf/23-03_Vetting_Genetic_Associations.pdf
Applying Preventive Genomic Medicine in Clinical Practice (Navigenics, 2008); available at http://www.navigenics.com/static/pdf/physician/physician-whitepaper.pdf
Green, P. H. R. & Jabri, B. Lancet 362, 383–391 (2003).
Hunt, K. A. et al. Nature Genet. 40, 395–402 (2008).
Liu, Y. et al. PLoS Genet. 4, e1000041 (2008).
Lazarou, J., Pomeranz, B. H. & Corey, P. N. J. Am. Med. Assoc. 279, 1200–1205 (1998).
Pirmohamed, M. et al. Br. Med. J. 329, 15–19 (2004).
Sangkuhl, K., Berlin, D. S., Altman, R. B. & Klein, T. E. Drug Metab. Rev. 40, 539–551 (2008).
Personalized Medicine Coalition Personal Genomics and Industry Standards: Scientific Validity (2008); available at http://cancercontrol.cancer.gov/od/phg/docs/PMCSciValid.pdf
Prainsack, B. et al. Nature 456, 34–35 (2008).
Aulchenko, Y. S. et al. Nature Genet. 41, 47–55 (2009).
Lyssenko, V. et al. N. Engl. J. Med. 359, 2220–2232 (2008).
Meigs, J. B. et al. N. Engl. J. Med. 359, 2208–2219 (2008).
Adeyemo, A. & Rotimi, C. Public Health Genomics doi: 10.1159/000218711 (2009).
Easton, D. F. et al. Am. J. Hum. Genet. 81, 873–883 (2007).
Author information
Authors and Affiliations
Ethics declarations
Competing interests
Competing interests: PCN and SSM currently hold stock in Illumina, Inc.
Additional information
Supplementary information on the experimental methods.
See Editorial page 697 , and online at http://go.nature.com/VqPUE2 .
Supplementary information
Supplementary Information
Experimental methods and results. (PDF 93 kb)
Supplementary figures
Supplementary figures. (PDF 478 kb)
Rights and permissions
About this article
Cite this article
Ng, P., Murray, S., Levy, S. et al. An agenda for personalized medicine. Nature 461, 724–726 (2009). https://doi.org/10.1038/461724a
Published:
Issue Date:
DOI: https://doi.org/10.1038/461724a
- Springer Nature Limited
This article is cited by
-
Bayesian multilevel multivariate logistic regression for superiority decision-making under observable treatment heterogeneity
BMC Medical Research Methodology (2023)
-
Predictors of adverse psychological experiences surrounding genome-wide profiling for disease risk
Journal of Community Genetics (2018)
-
Estimation of the risk of a qualitative phenotype: dependence on population risk
Journal of Human Genetics (2017)
-
Primary care providers’ cancer genetic testing-related knowledge, attitudes, and communication behaviors: A systematic review and research agenda
Journal of General Internal Medicine (2017)
-
Theranostic barcoded nanoparticles for personalized cancer medicine
Nature Communications (2016)